234 related articles for article (PubMed ID: 32432324)
1. Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma.
Lin S; Cao C; Meng Y; Wu P; Gao P; Zhi W; Peng T; Wu P; Gui L
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32432324
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
[TBL] [Abstract][Full Text] [Related]
3. Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma.
Zhou J; Guo Y; Huo Z; Xing Y; Fang J; Ma G; Han Q; Wang M; Xu Q
Aging (Albany NY); 2021 Jan; 13(3):4503-4521. PubMed ID: 33495416
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analysis of gene expression data for the identification of critical genes in breast invasive carcinoma.
Li Y; Wang Y
Mol Med Rep; 2017 Dec; 16(6):8657-8664. PubMed ID: 28990063
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of inhibitor of differentiation/DNA-binding gene family in lung cancer using bioinformatics methods.
Xu S; Wang Y; Li Y; Zhang L; Wang C; Wu X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32003423
[TBL] [Abstract][Full Text] [Related]
6. NR3C2-Related Transcriptome Profile and Clinical Outcome in Invasive Breast Carcinoma.
Lu J; Hu F; Zhou Y
Biomed Res Int; 2021; 2021():9025481. PubMed ID: 33564687
[TBL] [Abstract][Full Text] [Related]
7. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer.
Sun M; Tang C; Liu J; Jiang W; Yu H; Dong F; Huang C; Rixiati Y
BMC Cancer; 2021 Jun; 21(1):696. PubMed ID: 34120621
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer.
Liu X; Wang W; Chen B; Wang S
Aging (Albany NY); 2024 Apr; 16(8):7188-7216. PubMed ID: 38643462
[TBL] [Abstract][Full Text] [Related]
10. Identification of LCN1 as a Potential Biomarker for Breast Cancer by Bioinformatic Analysis.
Yang Y; Li F; Luo X; Jia B; Zhao X; Liu B; Gao R; Yang L; Wei W; He J
DNA Cell Biol; 2019 Oct; 38(10):1088-1099. PubMed ID: 31424267
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
Wu M; Li Q; Wang H
Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
[TBL] [Abstract][Full Text] [Related]
12. A three-microRNA signature predicts clinical outcome in breast cancer patients.
Cheng D; He H; Liang B
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6386-6395. PubMed ID: 30338807
[TBL] [Abstract][Full Text] [Related]
13. RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.
Kajiho H; Kajiho Y; Frittoli E; Confalonieri S; Bertalot G; Viale G; Di Fiore PP; Oldani A; Garre M; Beznoussenko GV; Palamidessi A; Vecchi M; Chavrier P; Perez F; Scita G
EMBO Rep; 2016 Jul; 17(7):1061-80. PubMed ID: 27255086
[TBL] [Abstract][Full Text] [Related]
14. Identification of Genes with Prognostic Value in the Breast Cancer Microenvironment Using Bioinformatics Analysis.
Ren H; Hu D; Mao Y; Su X
Med Sci Monit; 2020 Apr; 26():e920212. PubMed ID: 32251269
[TBL] [Abstract][Full Text] [Related]
15. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M; Chen H; Wang M; Bai F; Wu K
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
[TBL] [Abstract][Full Text] [Related]
17. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
18. Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer.
Chen F; Han B; Meng Y; Han Y; Liu B; Zhang B; Chang Y; Cao P; Fan Y; Tan K
Aging (Albany NY); 2021 Aug; 13(16):20438-20467. PubMed ID: 34413268
[TBL] [Abstract][Full Text] [Related]
19. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
[TBL] [Abstract][Full Text] [Related]
20. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
